Alcala, Jianah Jane R.
HRN: 22-51-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2023
AMPICILLIN 250MG (VIAL)
08/10/2023
08/16/2023
IV
175
Q6
Pcapc
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes